Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 18F-fluorofuranylnorprogesterone PET/MRI for endometriosis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 18F-fluorofuranylnorprogesterone (18F-fluorofuranylnorprogesterone)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Endometriosis | Phase 2 | Status: RECRUITING